Genomictree, Inc.

Genomictree (228760 KOSDAQ) has specialized in de- veloping innovative non-invasive molecular diagnostics to satisfy the unmet needs of the IVD (In Vitro Diagnostics) market in the healthcare industry. Genomictree focuses on the early detection of cancers. It was founded in 2000 with a vision of 'Contribute to Improving the Quality of Healthy Life and Reducing Total Medical Costs'. Our goal is to develop biomarker-based, non-invasive molecular diagnostics for the early detection of cancers. Our core competencies: 1) Efficient discovery of meth- ylation biomarkers using our own biomarker discovery engine, 2) Accurate measuring techniques capable of detecting biomarkers present in minute amounts in bodily fluids (liquid biopsy)